Abstract
Objective
The aim of this study is to determine the sexual dysfunction in patient with retroperitoneal fibrosis (RPF) and also we explored probability of Peyronie’s disease (PD) in this patient group and to compare this with the controls.
Materials and methods
Ten of 17 male RPF patients formed the basis of this study. Patient’s age, concomitant diseases were recorded. The diagnosis of PD was based on a palpable penile plaque or acquired penile curvature. Age-matched 88 patients who were admitted to our outpatient clinic with elevated PSA level served as the control group. All patients were asked to complete the IIEF-5 questionnaire. The severity of the erectile dysfunction (ED) was classified into four categories: severe (5–7), moderate (8–16), mild (17–21), and no ED (22–25). Concomitant systemic diseases were recorded. Statistical analyses were done by the Fisher’s exact test and an unpaired-sample t-test.
Results
Patients with severe ED or no sexual intercourse in the study group and the control group during the study period were found to be 7 and 14, respectively. The median IIEF-5 score in RPF patients and the control group was 9.8 (min: 5 to max: 23) and 19 (min: 5 to max: 25), respectively. The differences between groups were statistically significant (P = 0.002). In particular, ED was reported in eight RPF patients (80%) which was severe in six (60%) and moderate in two (20%). ED was reported in 45 patients in the control group (51%) which was severe in 14 (15.9%), mild in 25 (28.4%), and moderate in six (6.8%). Patients with RPF had a significant tendency for severe ED compared with the control group (P = 0.0042). Two patients in the RPF group (20%) and one patient in the control group (1.1%) were found to have a penile plaque (P = 0.0279). Relative risk for developing a penile plague was found to be 0.8 in RPF.
Conclusion
RPF patients are found to be more prone to developing ED. Penile plaque formation was identified in RPF patients, which may be presumed to relate to the pathological changes of the RPF process, but it remains unclear that these patients demonstrate a higher incidence of plaque formation than the normal population.
Similar content being viewed by others
Abbreviations
- RPF:
-
Retroperitoneal fibrosis
- PD:
-
Peyronie’s disease
- ED:
-
Erectile dysfunction
- IIEF-5:
-
International index of erectile function-5
- TGF-β1:
-
Transforming growth factor b1
- PSA:
-
Prostate specific antigen
References
Debruyne FM, Bogman MJ, Ypma AF (1982) Retroperitoneal fibrosis in the scrotum. Eur Urol 8(1):45–48
Buff DD, Bogin MB, Faltz LL (1989) Retroperitoneal fibrosis: report of selected cases and a review of the literature. N Y State J Med 89(9):511–516
van Bommel EFH, van Spengler J, van der Hoven B et al (1991) Retroperitoneal fibrosis: report of 12 cases and review of the literature. Neth J Med 39:338–345
Birnberg FA, Vinstein AL, Gorlick G et al (1982) Retroperitoneal fibrosis in children. Radiology 145:59–61
Koep L, Zuidema GD (1977) The clinical significance of retroperitoneal fibrosis. Surgery 81:250–257
Gilkeson GS, Allen NB (1996) Retroperitoneal fibrosis. A true connective tissue disease. Rheum Dis Clin North Am 22:23–38
Haag SM, Hauck EW, Szardening-Kirchner C et al (2007) Alterations in the transforming growth factor (TGF)-beta pathway as a potential factor in the pathogenesis of Peyronie’s disease. Eur Urol 51(1):255–261
Wespes E, Amar E, Hatzichristou DG et al (2002) EAU guidelines on erectile dysfunction (Update March 2004). Eur Urol 41:1–5
Rosen RC, Cappelleri JC, Smith MD et al (1999) Development and evaluation of an abridged, 5-item version of the international index of erectile function (IIEF-5) as a diagnostic tool for erectile function. Int J Impot Res 11:319–326
Bellastella A, Esposito D, Conte M et al (2005) Sexuality in aging male. J Endocrinol Invest 28(11):55–60
Drieskens O, Blockmans D, van den Bruel A et al (2002) Riedel’s thyroiditis and retroperitoneal fibrosis in multifocal fibrosclerosis: positron emission tomography findings. Clin Nucl Med 27:413–415
Dehner LP, Coffin CM (1998) Idiopathic fibrosclerotic disorders and other inflammatory pseudotumors. Semin Diagn Pathol 15:161–173
Hellstrom HR, Perez-Stable EC (1966) Retroperitoneal fibrosis with disseminated vasculitis and intrahepatic sclerosing cholangitis. Am J Med 40:184–187
Smith BH (1966) Peyronie’s disease. Amer J Clin Path 45:670–678
Schwarzer U, Sommer F, Klotz T et al (2001) The prevalence of Peyronie’s disease: results of a large survey. BJU Int 88:727–730
Kadioglu A, Oktar T, Kandirali E et al (2004) Incidentally diagnosed Peyronie’s disease in men presenting with erectile dysfunction. Int J Impot Res 16:540–543
Kadioglu A, Tefekli A, Erol B et al (2002) A retrospective review of 307 men with Peyronie’s disease. J Urol 168(3):1075–1079
El-Sakka AI, Hassoba HW, Pillarisetty RJ (1997) Peyronie’s disease is associated with an increase in transforming growth factor-beta protein expression. J Urol 158:1391–1394
Anderson MS, Shankey TV, Lubrano T et al (2000) Inhibition of Peyronie’s plaque fibroblast proliferation by biologic agents. Int J Impot Res 12(Suppl 3):25–31
Somers KD, Dawson DM, Wright GL et al (1982) Cell culture of Peyronie’s disease plaque and normal penile tissue. J Urol 127(3):585–588
Kanazawa S, Miyake T, Kakinuma T et al (2005) The expression of platelet-derived growth factor and connective tissue growth factor in different types of abdominal aortic aneurysms. J Cardiovasc Surg (Torino) 46(3):271–278
Ramshaw AL, Roskell DE, Parums DV (1994) Cytokine gene expression in aortic adventitial inflammation associated with advanced atherosclerosis (chronic periaortitis). J Clin Pathol 47(8):721–727
Moriya H, Ishida A, Nakabayashi I et al (1999) Juxtaglomerular cell tumor with retroperitoneal fibrosis and secondary immune-complex glomerulonephritis: a possible contribution of the renin angiotensin system to renal fibrosis. Am J Kidney Dis 34(3):10
Mulhall JP, Branch J, Lubrano T et al (2003) Radiation increases fibrogenic cytokine expression by Peyronie’s disease fibroblasts. J Urol 170(1):281–284
Whelan JS, Reznek R, Daniell SJN et al (1991) Computed tomography (CT) and ultrasound (US) guided core biopsy in the management of non-Hodgkin’s lymphoma. Br J Cancer 63(3):460–462
Mitchinson MJ (1970) The pathology of idiopathic retroperitoneal fibrosis. J Clin Path 23:681–689
Akkus E, Carrier S, Baba K et al (1997) Structural alterations in the tunica albuginea of the penis: impact of Peyronie’s disease, ageing and impotence. Br J Urol 79:47–53
El-Sakka AI (2006) Prevalence of Peyronie’s disease among patients with erectile dysfunction. Eur Urol 49(3):564–569
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Akbal, C., Tanıdır, Y., Özgen, M.B. et al. Erectile dysfunction and Peyronie’s disease in patient with retroperitoenal fibrosis. Int Urol Nephrol 40, 971–975 (2008). https://doi.org/10.1007/s11255-008-9381-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-008-9381-4